| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/10/2002 | WO2002002001A2 Epithelial diagnostic aid |
| 01/10/2002 | WO2002002000A2 Methods of screening for alzheimer's disease |
| 01/10/2002 | WO2002001950A2 Transgenic mice containing targeted gene disruptions |
| 01/10/2002 | WO2002001949A2 Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on the oestrogen receptor and its intracellular receptors, and method for the preparation thereof |
| 01/10/2002 | WO2001094636A8 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 01/10/2002 | WO2001074164A9 Methods of modulating hair growth |
| 01/10/2002 | WO2001071344A3 Immunochromatographic assay method and apparatus |
| 01/10/2002 | WO2001055952A9 Method and system for collecting and transmitting chemical information |
| 01/10/2002 | WO2001053349A3 Small cell lung cancer associated antigens and uses therefor |
| 01/10/2002 | WO2001051924A3 Method for determining the response to cancer therapy |
| 01/10/2002 | WO2001051651A3 High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam) |
| 01/10/2002 | WO2001049708A3 Peptide ligands that mimic sensor kinases and inhibit response regulators |
| 01/10/2002 | WO2001048483A3 Method for screening of appetite control agents |
| 01/10/2002 | WO2001048145A3 High affinity tcr proteins and methods |
| 01/10/2002 | WO2001047504A3 β-TUBELIN INHIBITORS AND THEIR USE AGAINST CANCER |
| 01/10/2002 | WO2001046697A3 Identification, assessment, prevention, and therapy of breast cancer |
| 01/10/2002 | WO2001046398A3 Aspartyl proteases |
| 01/10/2002 | WO2001045730A3 Tweak receptor |
| 01/10/2002 | WO2001045495A3 Potassium channel stress-related proteins and methods of use in plants |
| 01/10/2002 | WO2001044269B1 Brain protein markers |
| 01/10/2002 | WO2001043691A3 Fragments and antagonists of heat shock protein 60 |
| 01/10/2002 | WO2001042788A3 Analyte assay device with preabsorbing zone |
| 01/10/2002 | WO2001042786A3 System for cell based screening : cell spreading |
| 01/10/2002 | WO2001042437A3 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 01/10/2002 | WO2001041543A3 Pesticidal activity of functionalized alkenes |
| 01/10/2002 | WO2001040755A3 A novel and practical serological assay for the clinical diagnosis of leishmaniasis |
| 01/10/2002 | WO2001040279A3 Hbv sequences |
| 01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 01/10/2002 | WO2001038560A3 Active enzyme detection using immobilized enzyme inhibitors |
| 01/10/2002 | WO2001038344A3 Modulation of signal transduction |
| 01/10/2002 | WO2001037850A3 Use of a milk protein hydrolysate in the treatment of diabetes |
| 01/10/2002 | WO2001036474A3 Srik a novel cell cycle protein associated with rip3 |
| 01/10/2002 | WO2001036472A3 Compositions and methods for regulating tumor-associated antigen expression |
| 01/10/2002 | WO2001034302A3 Biochannel assay for hybridization with biomaterial |
| 01/10/2002 | WO2001033230A3 Biological sample component purification and differential display |
| 01/10/2002 | WO2001028594A3 Tumor detection by imaging and therapy of tumors |
| 01/10/2002 | WO2001026609A3 Method and apparatus for determining the effect of a drug on cells |
| 01/10/2002 | WO2001025410A3 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 01/10/2002 | WO2001018050A3 T2r taste receptor family |
| 01/10/2002 | WO2001002600A3 Detection of analytes using attenuated enzymes |
| 01/10/2002 | WO2001000829A3 Human endogenous retrovirus in breast cancer |
| 01/10/2002 | WO2000079274A3 Methods for assaying subcellular conditions using energy transfer |
| 01/10/2002 | WO2000072012A3 Apparatus for pretreating a sample containing an analyte |
| 01/10/2002 | WO2000060119A3 Methods for detecting cancer cells |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | US20020004938 Models of prion disease |
| 01/10/2002 | US20020004937 Method for detecting an aberrant animal-derived prion gene and a prion gene modified mouse which exhibits heart anomalies |
| 01/10/2002 | US20020004589 Detecting sensitivity to kidney disease |
| 01/10/2002 | US20020004586 Prion-binding activity in serum and proteins |
| 01/10/2002 | US20020004585 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 01/10/2002 | US20020004581 Polypeptide; for use in te diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004580 Polypeptide; for use in the diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004513 Azacyclic compounds |
| 01/10/2002 | US20020004495 Methods for stimulating bone formation |
| 01/10/2002 | US20020004489 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | US20020004247 Assay method |
| 01/10/2002 | US20020004246 Immunochromatographic methods for detecting an analyte in a sample which employ semiconductor nanocrystals as detectable labels |
| 01/10/2002 | US20020004245 Chromatographic assay or test device |
| 01/10/2002 | US20020004244 Measurement of solubility-pH profiles |
| 01/10/2002 | US20020004227 Nucleotide sequences coding immunoglobulins; for use in treating cancer |
| 01/10/2002 | US20020004219 Diagnosis of bacteria infections |
| 01/10/2002 | US20020004217 Biosensor |
| 01/10/2002 | US20020004216 Optical amplification of molecular interactions using liquid crystals |
| 01/10/2002 | US20020004215 Adjusting preferental particles to generate signal; mix ligand and marker, enzyme, incubate, allow binding, detect signal |
| 01/10/2002 | US20020004212 Monitoring defects in humans; prepare sample, block preferential receptors, incubate with lymphocytes, phagocytes and immunological reagent, detect sample for immunological complexes |
| 01/10/2002 | US20020004211 Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes |
| 01/10/2002 | US20020004209 Detecting modulators of transcription; incubate cell containing human androgen and estrogen receptors, preferential protein and modulator, monitor cell for adjustment in transcriptional activity |
| 01/10/2002 | US20020004208 Generating nicotine antibodies in situ |
| 01/10/2002 | US20020004207 Method for diagnosing bone dysbolism |
| 01/10/2002 | US20020004206 Methods of screening for disease |
| 01/10/2002 | US20020004205 Method of investigating functional molecular interactions and reagents for use therein |
| 01/10/2002 | US20020004202 In vivo screen using chemical inducers of dimerization |
| 01/10/2002 | US20020004199 No wash bead assay, kit and procedure |
| 01/10/2002 | US20020004196 Knives for use in chemical analysis of blood |
| 01/10/2002 | US20020004195 Synthetic transcriptional modulators and uses thereof |
| 01/10/2002 | US20020004194 Detecting modulators of proteins associated with ionic mobility; obtain cell, incubate with amyloid protein, monitor cells for reduced ionic mobility |
| 01/10/2002 | US20020004140 Photosensitivity |
| 01/10/2002 | US20020004048 Hepatitis C virus asialoglycoproteins |
| 01/10/2002 | US20020004047 DNA encoding a novel RG1 polypeptide |
| 01/10/2002 | US20020004043 Cellular and animal models for diseases associated with altered mitochondrial function |
| 01/10/2002 | US20020004019 Fluid collection swab; expressor to release fluid onto grooved platform for testing; confirmation means in platform collects another portion of fluid; screening tools for disease such as HIV |
| 01/10/2002 | US20020003625 Axial pattern analysis and sorting instrument for multicellular organisms employing improved light scatter trigger |
| 01/10/2002 | US20020003623 Sample chip analyzing device and method for analyzing the same |
| 01/10/2002 | US20020003001 Surface tension valves for microfluidic applications |
| 01/10/2002 | US20020002857 Odor identifying apparatus |
| 01/10/2002 | DE10127935A1 Separating impurities from bulk materials comprises temporarily increasing current flow so that material and impurities rise from base of vessel |
| 01/10/2002 | DE10032015A1 Test strip analysis unit for bodily fluid, employs temperature history correction system which will not drain batteries |
| 01/10/2002 | DE10031978A1 Verfahren und Vorrichtung zur automatischen Zundererkennung aus Oberflächen von metallischem Bandgut, insbesondere von warmgewalztem Stahlband und Edelstahlband Method and apparatus for automatic scale recognition on surfaces of metallic strip, particularly hot-rolled steel band and stainless steel strip |
| 01/10/2002 | DE10031882A1 Sensor für Helium oder Wasserstoff Sensor for helium or hydrogen |
| 01/10/2002 | DE10031236A1 Verwendung von Carbonsäuren und anderen Additiven in Kombination mit kationischen Verbindungen zur Stabilisierung von Nukleinsäuren in biologischen Materialien Use of carboxylic acids and other additives in combination with cationic compounds to stabilize the nucleic acids in biological materials |
| 01/10/2002 | DE10030798A1 Kompetitives Assay-Verfahren Competitive assay method |
| 01/10/2002 | DE10030602A1 Verfahren und Vorrichtung zur Bestimmung des Feuchtegehalts in Mehrkomponentengemischen Method and apparatus for determining the moisture content in multicomponent mixtures |
| 01/10/2002 | DE10030053A1 Atemalkoholmeßgerät Atemalkoholmeßgerät |
| 01/10/2002 | CA2630062A1 Methods for treating graft versus host disease and immune disorders associated with rejection using a soluble ctla4 molecule |
| 01/10/2002 | CA2585012A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | CA2416292A1 Transgenic mice containing targeted gene disruptions |
| 01/10/2002 | CA2415125A1 Polynucleotide sequence assay |
| 01/10/2002 | CA2415123A1 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | CA2415103A1 Methods and compounds for modulating nuclear receptor coactivator binding |
| 01/10/2002 | CA2415098A1 Methods for encoding combinatorial libraries |